For Institutions
Corporate Services
Developers
Download
Help
About
Company Profile
License & Regulatory
Media coverage
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)
Posts & comments will be shown in Cantonese
Search...
Quote List
Quote List
Newamsterdam Pharma - CW27
(NAMSW.US)
Overview
News
Company Encyclopedia
View More
Newamsterdam Pharma - CW27
NAMSW.US
Shareholder
Ownership
%Owned
Share Chg
Report Date
No Data
News
View More
Newamsterdam Pharma - CW27 | 10-Q: FY2025 Q3 Revenue: USD 348 K
LB filings
·
11/05/2025 21:04
US
NAMSW
0.00%
LB filings
·
11/05/2025 21:04
US
NAMSW
0.00%
Newamsterdam Pharma - CW27 | 8-K: FY2025 Q3 Revenue: USD 348 K
LB filings
·
11/05/2025 21:03
US
NAMSW
0.00%
LB filings
·
11/05/2025 21:03
US
NAMSW
0.00%
Newamsterdam Pharma - CW27 | 10-Q: FY2025 Q2 Revenue: USD 19.15 M
LB filings
·
08/06/2025 19:01
US
NAMSW
0.00%
LB filings
·
08/06/2025 19:01
US
NAMSW
0.00%
Newamsterdam Pharma - CW27 | 8-K: FY2025 Q2 Revenue: USD 19.15 M
LB filings
·
08/06/2025 19:01
US
NAMSW
0.00%
LB filings
·
08/06/2025 19:01
US
NAMSW
0.00%
Newamsterdam Pharma - CW27 | 10-Q: FY2025 Q1 Revenue: USD 2.978 M
LB filings
·
05/08/2025 20:02
US
NAMSW
0.00%
LB filings
·
05/08/2025 20:02
US
NAMSW
0.00%